DNA-based vaccination against hepatitis B virus

Advanced Drug Delivery Reviews

Volumn 21, Issue 1, 1996, Pages 33-47

  Davis, Heather L ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antibodies; Chimpanzee; Cytotoxic T lymphocytes; DNA vaccine; Genetic immunization; HBV chronic carrier; Hepatitis B surface antigen; Mice; Plasmid DNA

Indexed keywords

ANTIGENS; CELLS; DNA; GENETIC ENGINEERING; IMMUNIZATION; IMMUNOLOGY; PHYSIOLOGICAL MODELS; PROTEINS; VIRUSES;

CHIMPANZEE; CYTOTOXIC T LYMPHOCYTES; DNA BASED VACCINATION; GENETIC IMMUNIZATION; HEPATITIS B VIRUS; PLASMID DNA; SURFACE ANTIGEN; TRANSGENIC MICE; VACCINATION;

VACCINES;

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PLASMID DNA; VACCINE;

ANIMAL MODEL; ANTIBODY TITER; CELLULAR IMMUNITY; CHIMPANZEE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; HEPATITIS B; HEPATITIS B VIRUS; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VACCINATION; VIRUS CARRIER;

EID: 0030581324     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(96)00015-4     Document Type: Review

References (51)

1. [1] Tiollais, P. and Buendia, M.A. (1991) Hepatitis B virus. Sci. Amer. 264, 48-54.
2. [2] Hadler, S.C. and Margolis, H.S. (1993) Epidemiology of hepatitis B virus infection. In: R.W. Ellis (Ed.), Hepatitis B Vaccines in Clinical Practise, Marcel Dekker Inc., New York, pp. 141-158.
3. [3] Ganem, D. and Varmus, H.E. (1987) The molecular biology of the hepatitis B viruses. Ann. Rev. Biochem. 56, 651-693.
4. [4] Gerlich, W.H. and Bruss, V. (1993) Functions of hepatitis B virus proteins and molecular targets for protective immunity. In: R.W. Ellis (Ed.), Hepatitis B Vaccines in Clinical Practise, Marcel Dekker Inc., New York, pp. 41-82.
5. [5] Centers for Disease Control (1987) Recommendations of the Immunization Practises Advisory Committee. Update on hepatitis B prevention. MMWR 36, 353.
6. [6] Murray, K., Bruce, S.A., Hinnen, A., Wingfield, P., van Erd, P.M.C.A., de Reus, A. and Schellekens, H. (1984) Hepatitis B virus antigens made in microbial cells immunize against viral infection. EMBO J. 3, 645-650.
7. [7] Iwarson, S., Tabor, E., Thomas, H.C., Snoy, P. and Gerety, R.J. (1985) Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology 88, 763-767.
8. [8] Purcell, R.H. and Gerin, J.L. (1987). Hepatitis B vaccines, past, present and future: Lessons for AIDS vaccine development, In: W. Robinson, K. Koike and H. Will (Eds.), Hepadna Viruses. Alan R. Liss, Inc., New York, pp. 465-479.
9. [9] Purcell, R.H. and Gerin, J.L. (1975) Hepatitis B subunit vaccine: A preliminary report of safety and efficacy tests in chimpanzees. Am. J. Med. Sci. 270, 395-399.
10. [10] Buynak, E.B., Roehm, R.R., Tytell, A.A., Bertland, A.U., Lampson, O.P. and Hilleman, M.R. (1976) Development and chimpanzee testing of a vaccine against human hepatitis B. Proc. Soc. Exp. Biol. Med. 151, 694-700.
11. [11] Maupas, P., Goudeau, A., Coursaget, P. and Drucker, J. (1976) Immunization against hepatitis B in man. Lancet 1, 1367-1370.
12. [12] Reesink-Brongers, E.E., Reesink, H.W., Brummelhuis, H.G.J., Schut, B.J.T., Dees, P.J., Lelie, P.N., Raap, A.K., Wilson-de Stürler, L.A., van Aken, W.G., Balner, H., van Eerd, P.M.C.A., van Schie, T.C., Stitz, L.W., van Steenis, B. and Feltkamp-Vroom, T.M. (1982) Preparation and evaluation of heat-inactivated HBsAg as a vaccine against hepatitis B. In: W. Szmuness, H.J. Alter. and J.E. Maynard (Eds.), Viral Hepatitis 1981 International Symposium, Ed: The Franklin Institute Press, Philadelphia, pp. 437-450.
13. [13] Maugh, T.H. (1980) Hepatitis B vaccine passes first major test. Science 210, 760-762.
14. [14] Stephenne, J. (1988) Recombinant versus plasma-derived hepatitis B vaccines: issues of safety immunogenicity and cost-effectiveness. Vaccine 6, 299-303.
15. [15] Hilleman, M.R. (1993) Plasma-derived hepatitis B vaccine: A breakthrough in preventive medicine. In: R.W. Ellis (Ed.), Hepatitis B Vaccines in Clinical Practise, Marcel Dekker Inc., New York, pp. 17-40.
16. [16] Gerety, R.J. (1988) Recombinant hepatitis B vaccines. In: A.J. Zuckerman (Ed.), Viral Hepatitis and Liver Disease, Alan R. Liss Inc., New York, pp. 1017-1024.
17. [17] Valenzuela, P., Medina, A., Rutter, W.J., Ammerer, G. and Hall, B.D. (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298, 347-350.
18. [18] Michel, M.L., Pontisso, P., Sobczak, E., Malpièce, Y, Streeck, R.E. and Tiollais, P. (1984) Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. USA 81, 7708-7712.
19. [19] Kane, M.A. (1993) Global control of hepatitis B through universal infant immunization. In: R.W. Ellis (Ed.), Hepatitis B Vaccines in Clinical Practise, Marcel Dekker Inc., New York, pp. 309-322.
20. [20] Hibberd, P.L., Rubin, R.H. and Dienstag, J.L. (1993) Needs unfulfilled by current hepatitis B vaccines. In: R.W. Ellis (Ed.), Hepatitis B Vaccines in Clinical Practise, Marcel Dekker Inc., New York, pp. 323-336.
21. [21] Kruskall, M.S., Alper, C., Awdeh, Z., Yunis, E.J. and Marcus-Bagley, D. (1992) The immune response to hepatitis B vaccine in humans: Inheritance patterns in families. J. Exp. Med. 175, 495-502.
22. [22] Moss, B., Smith, G.L., Gerin, J.L., and Purcell, R.H. (1984) Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311, 67-69.
23. [23] Lubeck, M.D., Davis, A.R., Chengalvala, M., Natuk, R.J., Morin, J.E., Molnar-Kimber, K., Mason, B.B., Bhat, B.M., Mizutani, S., Hung, P.P. and Purcell, R.H. (1989) Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc. Natl. Acad. Sci. USA 86, 6763-6767.
24. [24] Gerin, J.L., Purcell, R.H. and Lerner, R.A. (1985) Use of synthetic peptides to identify protective epitopes of the heptitis B surface antigen, Vaccines 85, Cold Spring Harbour: Cold Spring Harbour Laboratory Press, pp. 235-239.
25. [25] Thornton, G.B., Milich, D.R., Chisari, F., Mitamura, K., Kent, S.B., Neurath, R., Purcell, R.H., and Gerin, J.L. (1987) Immune response in primates to the pre-S2 region of hepatitis B surface antigen: Identification of a protective determinant. In: R.M. Chanock, R.A. Lerner, F. Brown, and H. Ginsberg (Eds.), Vaccines 87, Cold Spring Harbour Laboratory Press, Cold Spring Harbour, pp. 77-80.
26. [26] Davis, H.L., Michel, M.L. and Whalen, R.G. (1993) DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum. Molec. Genet. 2, 1847-1851.
27. [27] Michel, M.L., Davis, H.L., Schleef, M., Mancini, M., Tiollais, P. and Whalen, R.G. (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92 5307-5311.
28. [28] Neurath, A.R., Kent, S.B.H., Strick, N., Taylor, P. and Stevens, C.E. (1985) Hepatitis B virus contains pre-S gene-encoded domains. Nature 315, 154-156.
29. [29] Alberti, A., Cavalletto, D., Pontisso, P., Chemello, L., Tagariello, G. and Belussi, F. (1988) Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet June 25, 1421-1424.
30. [30] Itoh, Y., Takai, E., Ohnuma, H., Kitajima, K., Tsuda, F., Machida, A., Mishiro, S., Nakamura, T., Miyakawa, Y. and Mayumi, M. (1986) A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: Protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. USA 83, 9174-9178.
31. [31] Neurath, A.R., Kent, S.B.H., Parker, K., Prince, A.M., Strick, N., Brotman, B. and Sproul, P. (1986) Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4, 35-37.
32. [32] Davis, H.L., Michel, M.L., Mancini, M., Schleef, M. and Whalen, R.G. (1994) Direct gene transfer in muscle with plasmid DNA for the purpose of nucleic acid immunization. Vaccine 12, 1503-1509.
33. [33] Davis, H.L., Demeneix, B.A., Quantin, B., Coulombe, J. and Whalen, R.G. (1993) Plasmid DNA is superior to viral vectors for direct gene transfer in adult mouse skeletal muscle. Hum. Gene Ther. 4, 733-740.
34. [34] Davis, H.L., Mancini, M., Michel, M.L. and Whalen, R.G. (1996) DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost. Vaccine (in press).
35. [35] Davis, H.L., Schirmbeck, R., Reimann, J. and Whalen, R.G. (1995) DNA-mediated immunization in mice induces a potent MHC class-I restricted cytotoxic T lymphocyte response to the heptitis B envelope protein. Hum. Gene Ther. 6, 1447-1456.
36. [36] Schirmbeck, R., Melber, K., Kuhröber, A., Janowicz, Z.A. and Reimann, J. (1994) Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class !-restricted CD8 + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152, 1110-1119.
37. [37] Milich, D.R. (1988) T-and B-cell recognition of hepatitis B viral antigens. Immunol. Today 9, 380-386.
38. [38] Babinet, C., Farza, H., Morello, D., Hadchouel, M. and Pourcel, C. (1985) Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230, 1160-1163.
39. [39] Guidotti, L.G., Ando, K., Hobbs, M.V., Ishikawa, T., Runkel, L., Schreiber, R.D. and Chisari, F.V. (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 3764-3768.
40. [40] Mancini, M., Hadchouel, M., Tiollais, P., Pourcel, C. and Michel, M.L. (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing 'nonresponse' to HBsAg. J. Med. Virol. 39, 67-74.
41. [41] Prince, A.M. (1981) The use of chimpanzees in biomedical research. US Department of Health and Human Services: Trends in Bioassay Methodology. In Bethesda Vivo, In Vitro and Mathematical Approaches, NIH Publication No 82-2382, pp. 81-98.
42. [42] Davies, H.L., McCluskie, M.J., Gerin, J.L. and Purcell, R.W. (1996) DNA vaccine for Hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA 93: (in press).
43. [43] Davis, H.L., Whalen, R.G. and Demeneix, B.A. (1993) Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151-159.
44. [44] Jiao, S., Williams, P., Berg, R.K., Hodgeman, B.A., Liu, L., Repetto, G. and Wolff, J.A. (1992) Direct gene transfer into nonhuman primate myofibers in vivo. Human Gene Ther. 3, 21-33.
45. [45] Coates, R.A., Halliday, M.L, Rankin, J.G., Stewart, J.D, Bristow, N.J., Granero, R. and West, D.J. (1988) Immunogenicity and safety of a yeast-derived recombinant DNA hepatitis B vaccine in health care workers. In: A.J. Zuckerman (Ed.), Viral Hepatitis and Liver Disease, Alan R. Liss Inc., New York, pp. 1038-1042.
46. [46] Yano, M. and Tashiro, A. (1988) Clinical evaluation of recombinant yeast-derived hepatitis B vaccine. In: A.J. Zuckerman (Ed.), Viral Hepatitis and Liver Disease, Alan R Liss Inc., New York, pp. 1050-1052.
47. [47] Raz, E., Carson, D.A., Parker, S.E., Parr, T.B., Abai, A.M., Aichinger, G., Gromkowski, S.H., Singh, M., Lew, D., Yankauckas, M.A., Baird, S.M. and Rhodes, G.H. (1994) Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519-9523.
48. [48] Cheng, L., Ziegelhoffer, P.R. and Yang, N.S. (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455-4459.
49. [49] Eisenbraun, M.D., Fuller, D.H. and Haynes, J.R. (1993) Examination of parameters affecting the elicitation of humoral immune responses by particle bombardmentmediated genetic immunization. DNA Cell. Biol. 12, 791-7.
50. [50] Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. (1993) DNA vaccines: Protective immunizations by parental, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
51. [51] Tang, D., DeVit, M. and Johnston, S.A. (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.